AU3892700A - Methods and compositions for inhibition of rna splicing - Google Patents

Methods and compositions for inhibition of rna splicing

Info

Publication number
AU3892700A
AU3892700A AU38927/00A AU3892700A AU3892700A AU 3892700 A AU3892700 A AU 3892700A AU 38927/00 A AU38927/00 A AU 38927/00A AU 3892700 A AU3892700 A AU 3892700A AU 3892700 A AU3892700 A AU 3892700A
Authority
AU
Australia
Prior art keywords
inhibition
compositions
methods
rna splicing
splicing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38927/00A
Other languages
English (en)
Inventor
Matthew D. Disney
Sergei M Gryaznov
Stephen M. Testa
Douglas H. Turner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geron Corp
University of Rochester
Original Assignee
Geron Corp
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geron Corp, University of Rochester filed Critical Geron Corp
Publication of AU3892700A publication Critical patent/AU3892700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/13Decoys
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/314Phosphoramidates
    • C12N2310/3145Phosphoramidates with the nitrogen in 3' or 5'-position

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU38927/00A 1999-03-15 2000-03-15 Methods and compositions for inhibition of rna splicing Abandoned AU3892700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12445199P 1999-03-15 1999-03-15
US60124451 1999-03-15
PCT/US2000/007045 WO2000055374A1 (fr) 1999-03-15 2000-03-15 Méthodes et compositions servant à inhiber l'épissage de l'arn

Publications (1)

Publication Number Publication Date
AU3892700A true AU3892700A (en) 2000-10-04

Family

ID=22414960

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38927/00A Abandoned AU3892700A (en) 1999-03-15 2000-03-15 Methods and compositions for inhibition of rna splicing

Country Status (2)

Country Link
AU (1) AU3892700A (fr)
WO (1) WO2000055374A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849484A (en) * 1992-07-30 1998-12-15 University Of Medicine & Dentistry Of Nj In vitro assay for inhibitors of the intron self-splicing reaction in Pneumocystis carinii

Also Published As

Publication number Publication date
WO2000055374A1 (fr) 2000-09-21

Similar Documents

Publication Publication Date Title
AU2625501A (en) Compositions and methods for gene silencing
AU4677399A (en) Inhibitors of H+K+-ATPase
AU3867400A (en) Methods of using bioelastomers
AU2913701A (en) System and method for facilitating selection of benefits
EP1177277A4 (fr) Compositions et procedes convenant a la modification de la transcription de genes
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU7389300A (en) Methods of administration of glycopyrrolate compositions
HUP0102782A3 (en) Salycilanilide as inhibitors of transcription factor nf-kb
AU6111000A (en) Inhibitors of viral helcase
AU2599800A (en) Methods and compositions for isolation of nucleic acid molecules
AU2001245987A1 (en) Compositions and methods for gene therapy
AU1488501A (en) Methods of inhibiting metastasis
AU2001288395A1 (en) Method for enhanced delivery of oxybutynin and compositions thereof
AU2674399A (en) Compositions and methods for the inhibition of muc-5 mucin gene expression
AU1410801A (en) Variants of alternative splicing
AU6094200A (en) Nor gene compositions and methods for use thereof
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU6678398A (en) Inhibitors of isoprenyl transferase
AU5632300A (en) Methods of inhibiting muscle atrophy
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
EP1163340A4 (fr) Compositions et methodes de modification de l'expression genique
AU3902799A (en) Compositions and methods for genetic transformation of pineapple
AU3892700A (en) Methods and compositions for inhibition of rna splicing
AU7666000A (en) Method of protecting wood

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase